{"id":310633,"date":"2019-12-19T22:00:35","date_gmt":"2019-12-20T06:00:35","guid":{"rendered":"https:\/\/nai500.com\/blog\/2019\/12\/metabomed\/"},"modified":"2019-12-19T23:33:59","modified_gmt":"2019-12-20T07:33:59","slug":"metabome-%e5%ae%8c%e6%88%90-1250-%e8%90%ac%e7%be%8e%e5%85%83%e7%9a%84%e8%9e%8d%e8%b3%87%e5%8a%a0%e9%80%9f%e5%80%99%e9%81%b8%e8%97%a5%e7%89%a9%e9%80%b2%e5%85%a5%e8%87%a8%e5%ba%8a","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hant\/blog\/2019\/12\/metabome-%e5%ae%8c%e6%88%90-1250-%e8%90%ac%e7%be%8e%e5%85%83%e7%9a%84%e8%9e%8d%e8%b3%87%e5%8a%a0%e9%80%9f%e5%80%99%e9%81%b8%e8%97%a5%e7%89%a9%e9%80%b2%e5%85%a5%e8%87%a8%e5%ba%8a\/","title":{"rendered":"Metabomed\u5b8c\u62101250\u842c\u7f8e\u5143\u7684\u878d\u8cc7\uff0c\u52a0\u901f\u5019\u9078\u85e5\u7269\u9032\u5165\u81e8\u5e8a"},"content":{"rendered":"<p>\u9818\u5148\u7684\u764c\u75c7\u4ee3\u8b1d\u516c\u53f8Metabomed\u5b8c\u6210\u4e861250\u842c\u7f8e\u5143\u7684\u878d\u8cc7\uff0c\u4f7f\u8fc4\u4eca\u70ba\u6b62\u7c4c\u96c6\u7684\u8cc7\u91d1\u7e3d\u984d\u9054\u52303000\u842c\u7f8e\u5143\u3002\u8a72\u516c\u53f8\u5ba3\u4f48\u65e8\u5728\u52a0\u901f\u9776\u5411\u4f9d\u8cf4\u4e59\u9178\u916f\u4ee3\u8b1d\u7684\u764c\u75c7\u4e2d\u7684\u4e59\u91af\u8f14\u9176A\u77ed\u93c8\u5408\u91762\u9176\uff08ACSS2\uff09\u6291\u5236\u4f5c\u7528\u7684\u81e8\u5e8a\u5019\u9078\u85e5\u7269\u3002<\/p>\n<p>\u8a72\u8f2a\u878d\u8cc7\u7531Yonjin Venture\u727d\u982d\uff0c\u6240\u6709\u73fe\u6709\u6295\u8cc7\u8005\u53c3\u8207\u5176\u4e2d\uff1aM Ventures\uff0cPfizer Ventures\uff0cPontifax Venture Fund\uff0cBoehringer Ingelheim Venture Fund\u548cArkin Bio Ventures\u3002\u8a72\u8f2a\u878d\u8cc7\u7684\u6536\u76ca\u5c07\u7528\u65bc\u57282020\u5e74\u5e95\u4e4b\u524d\u5c07Metabomed\u7684ACSS2\u8a08\u5283\u81e8\u5e8a\u5019\u9078\u85e5\u7269\u8f49\u70ba\u81e8\u5e8a\u8a66\u9a57\u6279\u51c6\uff0c\u4e26\u52a0\u5f37\u5176\u5167\u90e8\u6e20\u9053\u4ee5\u9032\u4e00\u6b65\u958b\u767cMetaboMed\u7684\u5176\u4ed6\u8a08\u5283\u7684\u5148\u5c0e\u5316\u5408\u7269\u3002<\/p>\n<p>Metabomed\u9996\u5e2d\u57f7\u884c\u5b98\u517c\u806f\u5408\u5275\u59cb\u4ebaSimone Botti\u535a\u58eb\u8aaa\uff1a\u201c\u6211\u5011\u5f88\u69ae\u5e78\u5c07Yonjin Venture\u5217\u5165Metabomed\u7684\u9802\u7d1a\u6295\u8cc7\u8005\u540d\u55ae\uff0c\u6211\u5011\u5c0d\u73fe\u6709\u80a1\u6771\u7684\u4fe1\u4efb\u6295\u7968\u611f\u5230\u9ad8\u8208\u3002\u6211\u5011\u5c0d\u6240\u6709\u8a08\u5283\u7684\u9032\u5c55\u611f\u5230\u8208\u596e\uff0c\u5c24\u5176\u662f\u6709\u6a5f\u6703\u5c07\u4e00\u6d41\u7684ACSS2\u6291\u5236\u5291\u63a8\u5411\u66f4\u9760\u8fd1\u8a3a\u6240\u7684\u6a5f\u6703\u3002\u6211\u5011\u5e0c\u671b\u80fd\u5920\u5f88\u5feb\u8868\u660e\uff0c\u91dd\u5c0d\u764c\u75c7\u7684\u5408\u6210\u81f4\u6b7b\u6027\u4ee3\u8b1d\u8106\u5f31\u6027\u7684\u65b9\u6cd5\u5c07\u5728\u81e8\u5e8a\u4e0a\u5f97\u5230\u8b49\u660e\uff0c\u4f8b\u5982\u7528\u4f5c\u6cbb\u7642\u4e09\u9670\u6027\u4e73\u817a\u764c\uff0c\u76ee\u524d\u7684\u6cbb\u7642\u6a19\u6e96\u4e0d\u80fd\u70ba\u8a31\u591a\u60a3\u8005\u63d0\u4f9b\u6709\u6548\u7684\u6cbb\u7642\u65b9\u6cd5\u3002\u201d<\/p>\n<p>\u8a72\u516c\u53f8\u8463\u4e8b\u9577David Aviezer\u6559\u6388\u88dc\u5145\u8aaa\uff1a\u201c\u901a\u904e\u9019\u4e00\u8f2a\u878d\u8cc7\uff0cMetabomed\u6191\u85c9\u5176\u9818\u5148\u7684\u5316\u5408\u7269\u8fc5\u901f\u9032\u5165\u81e8\u5e8a\u8a66\u9a57\u968e\u6bb5\uff0c\u4e26\u9032\u4e00\u6b65\u52a0\u5f37\u4e86\u5176\u6709\u524d\u9014\u7684\u7522\u54c1\u7dda\u3002\u201d<\/p>\n<p>Yonjin Venture\u8463\u4e8b\u7e3d\u7d93\u7406Daguang Wang\u8868\u793a\uff1a\u201c\u6211\u5011\u5f88\u9ad8\u8208\u6210\u70ba\u764c\u75c7\u4ee3\u8b1d\u9818\u57df\u9818\u5c0e\u8005Metabomed\u7684\u4e00\u90e8\u5206\u3002\u6211\u5011\u671f\u5f85\u8457\u8207\u516c\u53f8\u53ca\u5176\u8463\u4e8b\u6703\u5408\u4f5c\u3002\u201d\u3002<\/p>\n<p>Metabomed\u662f\u4e00\u5bb6\u5728\u764c\u75c7\u4ee3\u8b1d\u9818\u57df\u7684\u85e5\u7269\u958b\u767c\u516c\u53f8\u3002\u901a\u904e\u5176\u5c08\u6709\u6280\u8853\uff0cMetabomed\u53ef\u4ee5\u8b58\u5225\u5728\u764c\u75c7\u4e2d\u7368\u7279\u51fa\u73fe\u4e14\u5c0d\u5176\u751f\u9577\u81f3\u95dc\u91cd\u8981\u7684\u4ee3\u8b1d\u9014\u5f91\u3002\u9019\u4e9b\u767c\u73fe\u88ab\u7528\u65bc\u958b\u767c\u5c08\u9580\u91dd\u5c0d\u91cd\u65b0\u7de8\u7a0b\u7684\u764c\u7d30\u80de\u4ee3\u8b1d\u4ee5\u963b\u6b62\u5176\u751f\u9577\u7684\u5c0f\u5206\u5b50\u3002\u7531\u65bc\u9019\u4e9b\u5206\u5b50\u6291\u5236\u4e86\u764c\u7d30\u80de\u7279\u6709\u7684\u767c\u6563\u9014\u5f91\uff0c\u56e0\u6b64\u9019\u4e9b\u7642\u6cd5\u4e0d\u6703\u640d\u5bb3\u5065\u5eb7\u7684\u5468\u570d\u7d44\u7e54\u3002<\/p>\n<p>Yonjin Venture LLC\uff0c\u4f4d\u65bc\u99ac\u85a9\u8af8\u585e\u5dde\u528d\u6a4b\u5e02\uff0c\u662f\u4e2d\u570b\u4e0a\u6d77\u6c38\u9032\u96c6\u5718\u7684\u98a8\u96aa\u6295\u8cc7\u90e8\u9580\u3002Yonjin Venture LLC\u5c08\u696d\u5f9e\u4e8b\u5317\u7f8e\u548c\u6b50\u6d32\u7684\u751f\u547d\u79d1\u5b78\u6295\u8cc7\u3002<\/p>\n<p>\u82f1\u6587\u4f86\u6e90\uff1aBiospace<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Metabomed, a leading cancer metabolism company completed a financing of $12.5 million bringing the total raised to date to $30 million. The company announced that it has declared a clinical candidate for its first-in-class program targeting the inhibition of the AcetylCoA Short chain Synthase 2 enzyme (ACSS2) in cancers dependent on acetate metabolism.<\/p>\n","protected":false},"author":9,"featured_media":310625,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[194],"tags":[563,644,564],"class_list":["post-310633","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized_zh-hant","tag--zh-hant","tag-644","tag-564","sectors-life-science-zh-hant","locations-china-zh-hant","locations-us-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/310633","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=310633"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/310633\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/310625"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=310633"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=310633"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=310633"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}